Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Zepbound With Taltz Reduces Psoriasis and Psoriatic Arthritis Symptoms, Clinical Trials Show
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Lilly's Zepbound enhances Taltz in second psoriatic disease study
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Lilly chalks up another trial win for Zepbound-Taltz combo in bid to break down psoriasis, obesity 'silos'
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Eli Lilly’s Taltz-Zepbound combo scores in late-stage PsA study
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.